You are here

NantKwest

Nantkwest tries to catch the NK cell wave

EP Vantage

Thu, 01/14/21 - 10:43 am

natural killer cells

pancreatic cancer

ImmunityBio, NantKwest announce positive interim phase 1 safety data of hAd5 Covid-19 vaccine dose study

Pharmaceutical Business Review

Wed, 11/11/20 - 11:06 am

clinical trials

Patrick Soon-Shiong steps down as CEO of NantKwest, a linchpin of his 'Cancer Moonshot'

Endpoints

Tue, 10/27/20 - 10:42 am

Patrick Soon-Shiong

cancer moonshot

The Inside Story Of Biotech’s Barnum And His Covid Cures

Forbes

Thu, 08/27/20 - 12:39 pm

Patrick Soon-Shiong

NantKwest and ImmunityBio to initiate a phase 2 study of immunotherapy for metastatic pancreatic cancer

Pharmaceutical Business Review

Fri, 05/15/20 - 10:29 am

clinical trials

metastatic prostate cancer

Patrick Soon-Shiong ‘met with Donald Trump’ for NIH chief job

Fierce Biotech

Sun, 01/15/17 - 11:27 am

Pantrick Soon-Shiong

Back to the Lab for This Biotech’s Accounts

WSJ Online

Mon, 03/14/16 - 10:27 am

When These 3 Healthcare CEOs Speak, We Listen

Motley Fool

Sun, 10/11/15 - 01:55 pm

Gilead Sciences

Patrick Soon-Shiong

NantKwest's Successful IPO: An Indicator For The Biotech Industry, Both Good And Bad

Seeking Alpha

Sun, 08/2/15 - 11:23 am

Move over Juno: This company just had the largest biotech IPO ever

Bizjournals.com

Wed, 07/29/15 - 10:19 am

Juno Therapeutics